Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Report ID | 48144 |
Drug Identification Number | 02401320 |
Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
Common or Proper name | Piperacillin and Tazobactam for Injection |
Company Name | HIKMA CANADA LIMITED |
Market Status | DORMANT |
Active Ingredient(s) | PIPERACILLIN TAZOBACTAM |
Strength(s) | 3G 0.375G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 3.375 G/VIAL |
ATC code | J01CR |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2018-04-24 |
Estimated end date | 2018-05-10 |
Actual end date | 2018-05-14 |
Shortage status | Resolved |
Updated date | 2018-05-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-05-02 | English | Compare |
v2 | 2018-05-02 | French | Compare |
v3 | 2018-05-09 | English | Compare |
v4 | 2018-05-09 | French | Compare |
v5 | 2018-05-16 | English | Compare |
v6 | 2018-05-16 | French | Compare |
Showing 1 to 6 of 6